A single dose of baloxavir marboxil can significantly shorten the duration of the illness in teens and adults, according to a new study.
More specific targeting of molecules within cells could mean more effective treatments with fewer harmful effects.
Most drugs used to treat the types of inflammation that damages the brain in neurodegenerative diseases such as Alzheimer’s cannot get past the notorious “blood-brain barrier.”
A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing the problem.
School of Medicine researchers have identified promising drugs that could lead to the first antidote for radiation exposure that might result from a dirty bomb terror attack or a nuclear accident such as Chernobyl.